On Friday 25th January 2019, ERA celebrated their Silver Jubilee with an event at the Royal College of Physicians, London, consisting of a Scientific Meeting followed by a gala dinner. Baroness Greenfield was asked to speak on the future of ‘The Journey of Biopharmaceutical Development’. Her speech focused on the future of biopharmaceuticals and drug development and how this may challenge regulatory paradigms.
ERA Consulting was founded in 1993 by Dr Christopher Holloway, who sadly passed away in 2016, his vision was to support companies in the development of biopharmaceutical products by providing strategic regulatory consulting services. They specialise in the regulatory affairs, consulting services relating to biotech and biological products which has spanned over 20 years of service. Within these years, they have dealt with over 500 products including “natural” biologics, recombinant proteins, gene therapy and viable cell products, including engineered tissues. Many of the products involved were at the “cutting edge” of science and required appropriately innovative strategies.